Because radioactive precursors can be injected directly into the cell body or axon of R2, a giant, identified neuron of the Aplysia abdominal ganglion, it was possible to show that glycolipid is synthesized in the cell body, inserted into membranes along with glycoprotein, and then exported into the axon within organelles that are moved by fast axonal transport. After intrasomatic injection of N-[3H]-acetyl-D-galactosamine, five major 3H-glycolipids were identified using thin layer polysilicic acid glass fiber chromatography. At least two of the lipids are negatively charged. Analysis of 32P-labeled lipid from the abdominal ganglion revealed the presence of 2-aminoethylphosphonate, indicating that these polar substances are sphingophosphonoglycolipids. The major 3H-glycolipids synthesized in R2 are similar to a family of phosphonolipids isolated from the skin of A. kurodai, previously characterized by Araki et al. (Araki, S., Y. Komai, and M. Satake (1980) Biochem J. 87: 503-510). Since sialic acid is absent in Aplysia as in other invertebrates, these polar glycolipids may function like gangliosides in vertebrates. The polar 3H-glycolipids are synthesized and incorporated into intracytoplasmic membranes solely in the cell body. Direct injection of the labeled sugar into the axon revealed no local synthesis or exchange of glycolipid. Moreover, there was no indication for transfer from glial cells into axoplasm. Although the incorporation of N-[3H]-acetyl-~-galactosamine into glycolipid is not affected by anisomycin, an effective inhibitor of protein synthesis, the export into the axon of membranes containing the newly synthesized lipid is completely blocked by the drug. This can be explained if a cellular mechanism operates that permits the export only of organelles with a normal complement of lipid and protein. When exported into the axon, the 3H-glycolipids are transported at a rate of at least 40 to 70 mm/day at 15°C.
Proteins are synthesized in the neuronal soma. Those destined for the axon or synaptic terminals are packaged into organelles to be rapidly transported from the cell body (see Grafstein and Forman, 1980) . Lipids also are important components of synaptic membranes, but it remains to be determined whether they all originate in the cell body or whether some can be synthesized locally in the axon or contributed by glial cells (Forman and Ledeen, 1972; Holm, 1972; Grafstein and Forman, 1980) . Experiments to answer this question are difficult to perform in heterogeneous and complex nervous tissue. We have previously examined the origin of vesicle glycoproteins using R2, an identified giant neuron of Aplysia (Ambron et al., 1981a ). R2's cell body is the largest in the abdominal ganglion (0.8 mm in diameter), and its axon runs unbranched in the right pleuroabdominal connective, ultimately to synapse on glands in the animal's skin (Rayport et al., 1983) .
In this report, we extend our earlier work (Sherbany et al., 1979) on the source of R2's membrane glycolipids. 3H-labeled sugars which serve as glycolipid precursors can be injected directly into R2's cell body or axon. Since incorporated radioactivity is restricted to the injected neuron, regional synthetic capabilities can be determined unambiguously (Ambron et al., 1974a; Thompson et al., 1976; Sherbany et al., 1979) . The glycoproteins and glycolipids of the glial cells and connective tissue that surround axons can also be labeled preferentially by incubating connectives in the presence of radioactive precursors (Ambron and Treistman, 1977) . Consequently, it is possible to examine unequivocally the origin of the glycolipids that are rapidly transported in membranous organelles along R2's axon. In addition, they can be characterized chemically. Gangliosides, which are important in the vertebrate nervous system (Fishman and Brady, 1976; Ledeen et al., 1976; Yamakawa and Nagai, 1978) , appear to be absent from Aplysia (Komai et al., 1973) . Instead, we have found a class of phosphonoglycolipids that may serve the same functions as do gangliosides in vertebrates.
Materials and Methods
A. californica weighing 70 to 200 gm (supplied by Pacific Biomarine Supply Corp., Venice, CA) were maintained at 15°C in aerated, filtered Instant Ocean (Aquarium Systems, Eastlake, OH).
Incubation of nervous system in labeled sugar. Isolated abdominal ganglia with nerves and connectives attached were incubated at 15°C in 0.5 ml of sterile-filtered artificial sea water supplemented with amino acids (Eisenstadt et al., 1973) .
GalNAc, 25 Ci/mmol) and L-[1-14C]fucose (50 mCi/ mmol), purchased from New England Nuclear (Boston, MA), were added at a concentration of 4 pM; 1 pmol of N-[3H]acetylgalactosamine was equivalent to 10,500 cpm. Carrier-free 32Pi (Amersham, Arlington Heights, IL) was used in supplemented sea water with Ca++ omitted.
Intrasomatic and intra-axonal injection. Double-barreled electrodes for injecting [3H]-GalNAc into R2's cell body (Eisenstadt et al., 1973) and axon (Treistman and Schwartz, 1977) were prepared as previously described. After injection, the nervous system was maintained at 15°C in supplemented sea water. In some experiments, 4 to 5 hr before the intrasomatic injection, the isolated nervous system was exposed to 18 pM anisomycin (Ambron et al., 1975) . R2 was also injected in intact animals anesthetized with isotonic MgC12. An incision was made just beneath the right parapodium, and the abdominal ganglion was pinned to a stage at the end of a Lucite rod illuminated by fiber optics. After injection, the incision was sutured, and the animal was placed in a small aquarium (Sherbany, 1981) . Recovery was ascertained by active movement and feeding.
Dissection of R2's cell body and extrusion of axoplasm. The cell body was dissected from the ganglion and separated from surrounding neurons and neuropil. The intact nucleus, cytoplasm, and external envelope, consisting of R2's plasma membrane and associated glial cells, were isolated separately for fractionation (Ambron, 1982) . The right connective, severed from the abdominal ganglion, was placed in 0.1 ml of Ca++-free, supplemented artificial sea water containing 50 mM EGTA at 4°C. Axoplasm was extruded by drawing the connective gently through the tines of a forceps. Axoplasm and the remaining tissue in the connective were then fractionated separately.
Morphological techniques. Tissue was fixed in 6% glutaraldehyde-0.2 M collidine, postfixed in 1% (w/v) Os04, dehydrated, and embedded in Epoxy resin. Sections were stained with lead citrate and aqueous uranyl acetate and were examined on a Phillips EM 301 electron microscope (Thompson et al., 1976) .
Biochemical procedures
Fractionation. Details of the fractionation procedure have been described (Ambron et al., 1981a; Sherbany, 1981) . Because injected radioactive sugar precursors are incorporated only within the injected cell, and because labeled macromolecules remain localized to the cell and its axons (Ambron et al., 1974a; Thompson et al., 1976; Ambron and Treistman, 1977; Sherbany et al., 1979) , it was not necessary to separate the cell body or axon from the tissue for radiochemical analysis. Ganglia or connectives were homogenized and centrifuged at 105,000 x g. The supernate was treated with 5% trichloroacetic acid (TCA)-0.5% phosphotungstic acid, and the precipitate containing soluble glycoprotein was collected and counted.
The tissue pellet was sequentially treated at 4°C with 30 vol of chloroform:methanol (C:M) 2:1, followed by I:2 (v/v) to extract 3H-glycolipids quantitatively. After lipids were removed, 3H-glycoproteins were extracted from the pellet with 3% sodium dodecyl sulfate (SDS), 5% 2-mercaptoethanol at 70°C. The small amount of residual glycoprotein was solubilized with 90% aqueous formic acid. The sum of the radioactivity in these extracts was taken as the particulate glycoprotein content of the neuron. All of the radioactivity in R2 is recovered by these procedures.
Isolation of glycolipid. 3H-Lipids were fractionated on a silicic acid column (1.5 x 40 cm) (Rouser et al., 1967) by sequential elution with chloroform; chloroform: methanol, 2:l and 1:2; and chloroform:methanol: water (C:M:W) 10:10:3. 3H-Glycolipids A and B were eluted together from the silicic acid column with C:M:W, 10:10:3. They were concentrated under NB and then chromatographed on a column of DEAE-cellulose (DE 52, Whatman) . Both 3H-glycolipids were eluted from this column with C:M:ammonium carbonate (10:10:3).
Thin layer chromatography. Best resolution of the 3H-glycolipids was obtained with polysilicic acid glass fiber sheets (ITLC-Type 5A, Gelman, Ann Arbor, MI) developed with 1-propanol:water (P:W 80:20) . After the chromatogram was dry, it was developed again with 1% aqueous sodium tetraborate (modified from Chien et al., 1973) . Under these conditions, the lipids did not migrate, but nucleotide sugars, oligosaccharides, and glycopeptides produced by pronase digestion of Aplysia glycoproteins all moved with the solvent front (Sherbany, 1981) .
Ion exchange paper chromatography. 3H-Glycolipids were analyzed by ascending paper chromatography on ion exchange papers (Whatman CM82, DE81, and ET81) in C:M:W 10:10:3.
Acid hydrolysis. 3H-Glycolipids extracted from the 105,000 x g membrane pellet were hydrolyzed in 4 N HCl at 105°C for 8 hr. Under these conditions, [3H]GalNAc is completely deacylated to [3H]galactosamine. The hydrolysate was chromatographed in the descending direction using ethyl acetate:pyridine:acetic acidwater (5:5:1:3), a system that separates glucosamine from galactosamine (Ambron et al., 1981b) .
Methanolysis. Saponification of 3H-glycolipids was carried out in 0.1 M methanolic KOH for 15 min at 37°C (Ambron and Pieringer, 1971) . After adding water, the organic and aqueous phases were chromatographed on ITLC.
Enzymatic digestions. Digestion was carried out directly on ITLC sheets (modified after Naughton and Hagopian, 1962) . Material to be digested was applied together with 5 mg of pronase (beta grade, Cal Biochem, San Diego, CA) and 5 pg of bovine serum albumin labeled with Fluram (Roche Laboratories, Nutley, NJ) added to serve as a monitor for digestion. The plate was then sprayed with ammonium carbonate buffer until damp and suspended horizontally at 37°C in a sealed chamber. After 24 hr, the plate was dried and developed with P:W 80:20, followed by 1% aqueous sodium tetraborate. Similar experiments were carried out at 25°C with Escherichia coli alkaline phosphatase and phosphodiesterase I (type IV, Crotalus venom) both from Sigma Chemical Co. (St. Louis, MO).
Results
Appearance of 3H-glycolipid in R2's axon. Following a short lag after injection of [3H]GalNAc into R2's cell body, increasing amounts of labeled glycolipid were found in the axon; in contrast, soluble radioactivity appeared in the axon almost immediately ( Fig. 1) . At each time period examined, all of the 3H-glycolipid in both cell body and axon was particulate ( Table I ), implying that the glycolipid is associated with membranes. 3H-Membrane glycoprotein was also synthesized in R2 after injection of [3H]GalNAc. When the export of newly made glycoprotein and glycolipid was examined in the same cell, both classes of glycoconjugate appeared in the axon with similar kinetics (Fig. 2) . Coordinated movement would be expected if the glycoprotein and glycolipid are components of the same transported organelles (see be- low) and presuming that glycolipid, like glycoprotein, is synthesized only in the cell body. The labeled glycolipids from R2's cell body were similar to those that later appeared in the axon (Fig. 3) . Five glycolipids were resolved by polysilicic acid glass fiber chromatography (ITLC), three of which are highly polar. Vol. 4, No. 7, July 1984 hydrolyzed in acid. Several labeled compounds remained after hydrolysis, but most of the radioactivity migrated with 2-aminoethylphosphonate (Fig. 5) The same glycolipid classes were synthesized when R2 was injected with [3H]GalNAc in intact animals (see "Materials and Methods") and, therefore, are normal constituents of that neuron.
Characterization of 3H-glycolipids. The lipid nature of the labeled species is indicated by their solubility in organic solvents and their failure to migrate on thin layer chromatography with aqueous sodium tetraborate which causes water-soluble compounds to move to the solvent front. Upon methanolysis, which removes fatty acyl esters from glycerolipids, less than 5% of the radioactivity in the 3H-glycolipid fraction was released, and the chromatographic mobility of the five glycolipids was unchanged. Resistance to saponification is an indication that the compounds are sphingolipids.
Glycolipids A and B were isolated by column chromatography using silicic acid and DEAE-cellulose. Both components required high salt to be eluted from the ion exchange column. In addition, both remained at the origin of a cation exchange paper but migrated on anion exchange paper, indicating that they are negatively charged. To show that the anionic moiety is phosphate, Aplysia ganglia were exposed to 32Pi and the lipid fraction was separated by ITLC. Most of the radioactivity migrated near the front as expected of glycerol phospholipids, but two components had the same mobility as 3H-glycolipids A and B (Fig. 4) . Radioactivity migrating with 3H-glycolipid A was eluted from the chromatogram and Figure 4 was hydrolyzed in 6 N HCl at 100°C for 9 hr. The hydrolyzate was lyophilized, reconstituted in water, and chromatographed in the descending direction on Whatman 3MM paper with l-propanol:TCA:NH40H:water (75:5:0.3:25, v/w/v/v). The lane containing hydrolyzed lipid was cut into segments for counting and the 2-aminoethylphosphonate standard, which migrated 27 cm, was visualized with ninhydrin.
(1980) have'isolated a sphingophosphonoglycolipid from the skin of Aplysia kurodai. A sample of this lipid, designated SGL-II (generously provided by Professor M. Satake, Niigata University), migrated with 3H-glycolipid A in our ITLC system with P:W 80:20 and also on ITLC developed with 1-propanol:ammonium hydroxide:water (6:2:1) (not shown). According to Araki et al. (1980) and Araki and Satake (1981) , SGL-II contains galactosamine, glucose, and 3-methylgalactose. Because acid hydrolysis of 3H-glycalipid A yielded on chromatography both labeled galactosamine and glucosamine, we conclude that glycolipid A is a sphingophosphonoglycolipid which is similar to glycolipid SGL-II of A. kurodai, but that the two glycolipids probably are not identical.
Axons lack the capacity to synthesize glycolipid. To provide evidence that the 3H-glycolipid which appears in R2's axon originates in the cell body, [3H]GalNAc was injected directly into the axon of R2. No 3H-glycolipid was formed. We found that 0.5% to 2.7% of the total radioactivity was incorporated into chloroform:methanol-extractable material. When chromatographed, a prominent component was seen which migrated 8 cm from the origin (Fig. 6A ). This component is not a glycolipid by our criteria, however, because it moved to the front when the chromatogram was redeveloped with aqueous sodium tetraborate (Fig. 6B) . The identity of this axonal component has not yet been determined, but it is not GalNAc, galactosamine, uridine diphosphate (UDP)-GalNAc, or UDP-glucosamine.
Localization of 3H-glycolipid to the cell body and axon of R2. It was assumed in the above experiments that the 3H-glycolipids are localized to the injected neuron. Because of R2's large size, we were able to demonstrate this directly by dissecting R2's isolated cell body and extruding axoplasm from the right connective. In these experiments, 3H-glycoproteins were used as intracellular markers for the neuronal (somatic or axonal) compart- Figure 6 . Chromatography of chloroform:methanol extracts of R2's axon after intrasomatic or intra-axonal injection of [3H] GalNAc. A, After axon injection of [3H]GalNAc and developed with propanol:water; the total radioactivity on the chromatogram was 172 cpm. B, A sample of the same material chromatographed in A developed with propanol:water (front at 14 cm) followed by development with 1% borate (front at 17 cm); total radioactivity was 553 cpm. C, Radioactivity extracted from the segment of the axon distal to a colchicine cuff; total radioactivity was 700 cpm. D, Radioactivity from R2's axon after injection of [3H]GalNAc into R2's cell body in the presence of anisomycin; total radioactivity was 1089 cpm. Vol. 4, No. 7, July 1984 ment. Autoradiography of several identified Aplysia neurons, including R2, has revealed that labeled glycoproteins formed after injection of 3H-sugars are restricted to the cell body and its processes (Thompson et al., 1976; Ambron and Treistman, 1977; Ambron et al., 1980 Ambron et al., , 1981a . When R2's cell body was dissected, essentially all of the 3H-glycolipid and 3H-glycoprotein was contained in the isolated cytoplasm (Fig. 7A) . Differential centrifugation revealed that the labeled glycoconjugates are particulate, consistent with their being associated with internal membrane systems of the cell body. When the 3H-glycolipids were chromatographed, the pattern obtained was identical to those shown in Figure 3 for the undissected cell body.
We next drew the right connective containing R2's main axon gently through the tines of forceps 15 hr after intrasomatic injection of [3H]GalNAc. Electron microscopy of the connective after extrusion showed that most of the axolemma and supporting glial cells remained intact. Both 3H-glycolipid and 3H-glycoprotein were extruded to a similar extent (Fig. 7B) , and the extruded 3H-glycolipid had the same chromatographic pattern as did the lipid left behind in the connective. This result would be expected if all of the 3H-glycolipid in the connective was originally present in R2's axoplasm.
Extrusion experiments also provided evidence that glycolipids synthesized in glial cells and connective tissue that surround the axon are different from those produced by R2. This was determined by extruding axoplasm from connectives that had been incubated in the presence of ministering the precursor has been shown by autoradiography to label glycoprotein only in the supporting cells and glia that surround axons (Ambron and Treistman, 1977) . A much smaller proportion of the radioactivity in glycoprotein and glycolipid was extruded from the axon after incubation (Fig. 7B) . Moreover, the chromatographic pattern of these lipids from the right connective is different from that seen after injection of the labeled sugar (Fig. 3) ; glycolipids A and B are absent from glial cells. Instead, two other highly polar lipids are present. Similarly, the lipids formed in the tissue of the abdominal ganglion surrounding R2's cell body are different from those synthesized within the neuron (Fig. 3) .
To rule out possible variations in the tine pressure used to extrude axoplasm between those experiments in which cells were injected and those in which the tissue was incubated, we injected the cell body of R2 with [3H] GalNAc while incubating the nervous system in ['"Cl fucose. Using double label scintillation counting, we determined that 77% of 3H-glycolipid and 91% of 3H-glycoprotein were extruded from the connective, while only 16% of 14C-glycolipid and 8% of "C-glycoprotein were extruded. These results are similar to those obtained in the single label experiments above, indicating that there was no bias in technique between the injection and the incubation experiments.
Fast axonal transport of glycolipid. We used colchicine to show that the newly synthesized 3H-glycolipids are rapidly transported along R2's axon. This drug blocks rapid axonal transport in Aplysia Treistman and Schwartz, 1977) but allows soluble radioactive precursors to diffuse into the axon. A colchicine (10 mM) cuff around the proximal portion of the connective inhibited the appearance of 3H-glycolipid in the axon by 95 + 1% (n = 3) and 3H-glycoprotein by 97 & 3% (n = 3). Incorporation of injected precursor into glycolipid or glycoprotein in the cell body was not reduced in the presence of the cuff, and the usual chromatographic pattern of 3H-glycolipids was obtained from the cell body (not shown). On the other hand, chromatography of the radioactivity from the region of the axon distal to the cuff revealed the same component seen after intra-axonal injection (Fig. 6C) .
Additional evidence that glycolipid moves by fast transport was provided by examining the distribution of labeled lipid along the axon at various times after intrasomatic injection of [3H]GalNAc. By 15 hr not only was substantial 3H-glycolipid found in the axon 2 to 3 cm distal to the cell body, but it also was distributed in waves similar to those found for other rapidly transported constituents in single axons (Ambron et al., 1974b; 1981b; Goldman et al., 1976) . As the interval after injection increased, increasing amounts of the glycolipid were found further out along the axon.
It is difficult to determine rates of transport from these distributions because the moving front cannot be defined precisely. Goldberg et al. (1976) devised a method of graphing transport data that permits reliable comparison of the distributions of label between axons in different specimens. According to this method, the fraction of the label distal to each l-mm point along the axon is plotted as a function of the distance from the cell body. The distributions of 3H-glycolipids and 3H-glycoproteins plotted in this way overlap precisely for experiments at 5, 10, 15, or 22 hr after injection and are quite different from the distributions of acid-soluble radioactivity which moves by diffusion. These distributions are shown at 15 hr (Fig. 8) . By comparing the displacements at 15°C of the distalmost 0.5% of the total neuronal radioactivity in 3H-glycolipid at 10, 15, and 22 hr after injection, we estimate the rate of transport to range from 40 to 70 mm/day.
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Coordinate export of glycoprotein and glycolipid. The similarity in the kinetics of export for glycoprotein and glycolipid indicated that they may be inserted into membranes together. Additional evidence in favor of this idea was obtained by using anisomycin. Brief exposure to this inhibitor of protein synthesis blocks export of newly synthesized membrane glycoproteins from the cell body into the axon (Ambron et al., 1975) . Treatment of the isolated nervous system with anisomycin 4 to 5 hr before intrasomatic injection of [3H]GalNAc did not reduce incorporation into 3H-glycolipid in the cell body, but the appearance in the axon of both 3H-glycolipid and 3H-glycoprotein was reduced by more than 90% (Fig. 9) . As with colchicine, the appearance of soluble precursors in E 8 8 s L Glycolipid Glycoprotem Figure 9 . Effects of anisomycin on the incorporation of [3H] GalNAc into glycoconjugates and on their export from the cell body. Prior to intrasomatic injection, nervous systems were exposed to anisomycin (solid bars) or maintained in the supplemented sea water (open bars). The cell body and axon were separated and fractionated 22 hr after the injection (see "Materials and Methods"). A, Incorporation, 3H-glycoconjugates in the cell body are shown as a percentage of the total radioactivity in the neuron. B, Export, 3H-glycoconjugates in the axon are shown as a percentage of the total radioactivity in the neuron.
the axon is not inhibited by the drug, presumably because they diffuse into the axon. Chromatography of a chloroform:methanol extract from the particulate fraction of R2's axon after treatment with anisomycin yielded only one labeled component. This material migrated together with the axonal component seen after intra-axonal injection (Fig. 6D) and was swept to the front of the chromatogram with aqueous sodium tetraborate (not shown). Figure 8 . Spatial distribution of 3H-glycoconjugates and acidsoluble radioactivity along the axon of R2 15 hr after intrasomatic injection of [3H]GalNAc. The amounts of a component (3H-glycolipid, 3H-glycoprotein, or soluble) distal to each point along the axon are determined, these values, expressed as a percentage of the total radioactive component in the axon, are then plotted as a function of distance from the cell body. 0, 3H-Glycolipid (total radioactivity, 11,100 cpm). 0, Particulate 3H-glycoprotein (927,000 cpm). 0, Acid-soluble radioactivity (220,300 cpm). After injection, tissue was frozen and the right connective was severed just adjacent to the cell body in the abdominal ganglion. The connective was cut into l-mm sequential segments, and each segment was homogenized and fractionated. as described under "Materials and Methods."
Discussion
Biochemical characterization of the 3H-glycolipids. The chemical composition of the glycolipids synthesized by R2 after intrasomatic injection of [3H]GalNAc indicates that they are a class of sphingophosphonoglycolipids. Glycolipids A and B, like certain gangliosides of vertebrate cell membranes, are negatively charged and highly polar. In vertebrates, gangliosides contribute to the anionic surface charge of the membrane. They also serve as receptors, and it has been suggested that gangliosides impart specificity to neuronal membranes (Yamakawa and Nagai, 1978) . Gangliosides are not present in most invertebrates, however, and are absent from the Aplysia nervous system (Komai et al., 1973; NGren and Svennerholm, 1973; Ng and Dain, 1976) . Since it is likely that the functions mediated by gangliosides are assumed by other lipids in invertebrates, we suggest that the sphingophosphonoglycolipids fulfill the function of gangliosides in Aplysia.
The sphingophosphonoglycolipids found in R2 seem to be constituents of a heterogeneous family of related glycolipids. SGL-II, which was isolated from the skin of Aplysia kurodai (Araki et al., 1980) , has properties similar to glycolipid A but differs with regard to sugar composition. Similarly, as shown in Figure 3 , the glycolipid composition of glial cells and supporting tissue that surround R2 includes several highly polar species that are different from glycolipids A and B of R2. We also found differences in the glycolipids of R2 and of the giant cerebral neuron (GCN), an identified serotonergic neuron. GCN lacks plycolipid A, one of the major compo-Sherbal nents of R2's membranes (Sherbany, 1981) . Differences between GCN and R2 have also been found in membrane glycoproteins (Ambron et al., 1980) . Taken together, these observations suggest that characteristic glycoconjugates serve to distinguish the membranes of different cells, and this may be related to specificity of function.
Origin of glycolipids in the cell body. It is the general view that essentially all macromolecular constituents of neuronal membranes are synthesized in the nerve cell body (Schwartz, 1979; Grafstein and Forman, 1980) . We explored several possible origins of R2's glycolipids because extrasomatic synthesis of some macromolecules has been previously described. For example, the transfer of proteins from glial cells to axoplasm has been demonstrated in the squid (Lasek et al., 1977) . Moreover, the origin of the various types of lipids that constitute neuronal membranes may differ. Droz et al. (1978) have suggested that rapidly transported phospholipids are transferred from the axon to myelin, while in peripheral nerves, phosphatidylcholine synthesized by Schwann cells finds its way into axons (Kumara-Siri and Gould, 1980) . Several lines of evidence support the idea that the rapidly transported glycolipids found in R2's axon originates in the cell body. First, the axonal 3H-glycolipids are chemically indistinguishable from those labeled in the cell body. Second, the axon is unable to incorporate [3H]GalNAc into glycolipid. This is true whether the precursor is injected directly into the axon or is allowed to diffuse into the axon from the cell body (Fig. 6) . Restriction of the synthesis of glycolipids to the cell body is to be expected because Golgi membranes are the sole site of fucosylation (Morre, 1977) . Finally, it is unlikely that the axonal glycolipids originate in glial cells because the polar glycolipids made in glia differ chemically from those synthesized in the neuron.
Coordinated synthesis of 3H-glycolipids and 3H-glycoproteins. Synthesis and distribution of glycolipids and glycoproteins in R2 seem to be coordinated. The extent of incorporation of injected sugar into both glycoprotein and glycolipid showed a similar increase with time after intrasomatic injection and a similar dependence on the amount of [3H]GalNAc injected (Ambron et al., 1981a; Sherbany, 1981) . In addition, export into the axon of both kinds of glycoconjugates followed the same kinetics, and both were transported rapidly along the axon at similar rates. Glycolipids and glycoproteins are both constituents of membranes; presumably they are coordinately distributed because both are inserted into membranes of the same population of organelles. Ambron et al. (1975) found that the export of 3H-glycoproteins from R2's cell body into its axon is much more profoundly blocked than is their glycosylation by the application of anisomycin, a specific inhibitor of protein synthesis in Aplysia (Schwartz et al., 1971) . This observation led to the suggestion that continued synthesis of polypeptide is necessary for the export of newly synthesized membrane constituents (Ambron et al., 1975) . Similar observations have been made in the nervous systems of other animals, where inhibiting the synthesis of one type of membrane constituent results in ny et al. Vol. 4, No. 7, July 1984 blocking the export of all newly synthesized organelles (reviewed by Schwartz, 1979; Longo and Hammerschlag, 1980) . In the serotonergic GCN, Goldberg et al. (1978) showed that transmitter storage granules, assembled before exposure of the neuron to the inhibitor, continue to be exported long after application of anisomycin. In our present experiments with anisomycin, we find that inhibition of protein synthesis in R2 completely blocked the export of 3H-glycolipids, even though their synthesis in the cell body was totally unaffected. Thus, despite the existence of a normal complement of 3H-glycolipid, the somatic membranes formed in the presence of anisomytin are incomplete, presumably because the glycolipids in them have been inserted without concomitant insertion of protein. This and the other instances where the export of nascent organelles is blocked by inhibitors of either protein or lipid synthesis suggest that a mechanism exists in the cell body that tickets completed organelles for export into the axon while preventing the export of organelles that are not yet complete.
